Home4582 • TYO
add
Symbio Pharmaceuticals Ltd
Previous close
¥156.00
Day range
¥154.00 - ¥159.00
Year range
¥126.00 - ¥475.00
Market cap
7.38B JPY
Avg Volume
398.62K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
MarketWatch
20 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 553.63M | -52.60% |
Operating expense | 1.51B | 3.53% |
Net income | -987.98M | 15.85% |
Net profit margin | -178.45 | -77.54% |
Earnings per share | — | — |
EBITDA | -1.06B | -110.40% |
Effective tax rate | -0.61% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.96B | -39.19% |
Total assets | 4.97B | -39.19% |
Total liabilities | 773.00M | -19.48% |
Total equity | 4.20B | — |
Shares outstanding | 47.83M | — |
Price to book | 1.70 | — |
Return on assets | -49.20% | — |
Return on capital | -58.06% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -987.98M | 15.85% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 25, 2005
Headquarters
Website
Employees
108
